{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:49:45Z","timestamp":1791899385837,"version":"4.3.4"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>To examine preferences for human papillomavirus (HPV) specimen self-collection, and collection location, in a nationally representative sample of reproductive-aged women in the United States.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>This cross-sectional analysis used household population-based data from the National Survey of Family Growth (January 2022\u2013December 2023) and was limited to women aged 21\u201349 years without a history of hysterectomy or cervical cancer (sample n=4,465). Survey weights and design variables were applied to generate nationally representative population frequencies and percentages of preference for HPV self-collection compared with clinician collection, and preference for collection location (ie, at home or in office).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      Among eligible U.S. women, 42.9% preferred HPV self-collection, 28.5% preferred clinician collection, and 28.6% expressed no preference. An estimated 41.7 million (71.5%) U.S. women aged 21\u201349 years were open to HPV self-collection (either preferring it or having no preference), including 9.7 million women who were underscreened or never screened. Among women who were open to HPV self-collection, more than half (52.1%) preferred self-collection at home, 14.7% preferred to do self-collection in a doctor's office, and 33.2% had no preference for location. More underscreened or never-screened women preferred HPV self-collection (54.0%) and at-home collection (59.3%) compared with those who were up to date with screening (40.3% and 50.2%, respectively,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;.001). Preference for self-collection also varied by race and Hispanic origin, education, income, parity, sexual orientation, and prior experience of nonvoluntary vaginal intercourse.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>In this nationally representative study, more than 7 in 10 U.S. women aged 21\u201349 years were open to HPV self-collection for cervical cancer screening, with more than half favoring at-home collection. Preference was higher among women who were not up to date with screening. These findings provide timely evidence to inform future policy decisions and implementation strategies to improve access to cervical cancer screening.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aog.0000000000006147","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T22:00:16Z","timestamp":1765490416000},"page":"306-312","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Preferences Among U.S. Women for Cervical Cancer Screening with Self-Collected Specimens for Human Papillomavirus Testing"],"prefix":"10.1097","volume":"147","author":[{"given":"Jin","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gladys","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hunter K.","family":"Holt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer V.","family":"Gopalani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina F.","family":"Trivers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline W.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Senkomago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George F.","family":"Sawaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,12,11]]},"reference":[{"key":"R1-20260930","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.1002\/cam4.3951","article-title":"A population study of screening history and diagnostic outcomes of women with invasive cervical cancer","volume":"10","author":"Benard","year":"2021","journal-title":"Cancer Med"},{"key":"R3-20260930","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.2018.10897","article-title":"Screening for cervical cancer: US Preventive Services Task Force recommendation statement","volume":"320","author":"Curry","year":"2018","journal-title":"JAMA"},{"key":"R6-20260930","doi-asserted-by":"crossref","first-page":"k4823","DOI":"10.1136\/bmj.k4823","article-title":"Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses","volume":"363","author":"Arbyn","year":"2018","journal-title":"BMJ"},{"key":"R8-20260930","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/LGT.0000000000000885","article-title":"Self-collected vaginal specimens for HPV testing: recommendations from the enduring consensus cervical cancer screening and management guidelines committee","volume":"29","author":"Wentzensen","year":"2025","journal-title":"J Low Genit Tract Dis"},{"key":"R9-20260930","doi-asserted-by":"crossref","first-page":"e2511081","DOI":"10.1001\/jamanetworkopen.2025.11081","article-title":"Clinical validation of a vaginal cervical cancer screening self-collection method for At-Home use: a nonrandomized clinical trial","volume":"8","author":"Fitzpatrick","year":"2025","journal-title":"JAMA Netw Open"},{"key":"R11-20260930","doi-asserted-by":"crossref","first-page":"E94","DOI":"10.5888\/pcd20.230071","article-title":"Up-to-Date breast, cervical, and colorectal cancer screening test use in the United States, 2021","volume":"20","author":"Sabatino","year":"2023","journal-title":"Prev Chronic Dis"},{"key":"R12-20260930","doi-asserted-by":"crossref","first-page":"e003743","DOI":"10.1136\/bmjgh-2020-003743","article-title":"HPV self-sampling for cervical cancer screening: a systematic review of values and preferences","volume":"6","author":"Nishimura","year":"2021","journal-title":"BMJ Glob Health"},{"key":"R13-20260930","doi-asserted-by":"crossref","first-page":"108223","DOI":"10.1016\/j.ypmed.2025.108223","article-title":"U.S. national trends in cervical cancer screening by sexual orientation and race\/ethnicity in cisgender women","volume":"191","author":"Baumann","year":"2025","journal-title":"Prev Med"},{"key":"R14-20260930","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1177\/08862605241265431","article-title":"Trauma, PTSD, and self-efficacy: Predictors of cervical cancer screening in sexual violence survivors","volume":"40","author":"Bengtson","year":"2025","journal-title":"J Interpers Violence"},{"key":"R15-20260930","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1089\/jwh.2016.5965","article-title":"Clinician and patient acceptability of self-collected human papillomavirus testing for cervical cancer screening","volume":"26","author":"Mao","year":"2017","journal-title":"J Womens Health (Larchmt)"},{"key":"R16-20260930","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/09691413241260019","article-title":"Primary human papillomavirus testing by clinician- versus self-collection: awareness and acceptance among cervical cancer screening-eligible women","volume":"31","author":"MacLaughlin","year":"2024","journal-title":"J Med Screen"},{"key":"R17-20260930","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/sextrans-2016-052609","article-title":"The acceptability of self-sampled screening for HPV DNA: a systematic review and meta-analysis","volume":"93","author":"Nelson","year":"2017","journal-title":"Sex Transm Infect"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000006147","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T15:00:35Z","timestamp":1790780435000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000006147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,11]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000006147","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,11]]},"assertion":[{"value":"2025-07-10","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-11","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}